PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2149239
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2149239
The global gastrointestinal stent market size was valued at USD 615.8 million in 2025 and is projected to grow from USD 647.8 million in 2026 to USD 980.6 million by 2034, exhibiting a CAGR of 5.3% during the forecast period. North America dominated the global gastrointestinal stent market with a 41.88% share in 2025, supported by favorable reimbursement, advanced healthcare infrastructure, and increasing adoption of minimally invasive gastrointestinal procedures.
Gastrointestinal stents are flexible tubes made from metal, plastic, or biodegradable materials that are inserted into areas of the digestive tract, including the stomach, esophagus, intestine, or bile duct, to relieve blockages. Rising prevalence of biliary disease, esophageal cancer, colorectal cancer, and other gastrointestinal disorders is increasing demand for stenting procedures.
Market Definition and Scope
The gastrointestinal stent market includes biliary, duodenal, colonic, esophageal, and other stents used for managing gastrointestinal obstructions and related conditions. The market is segmented by material into metal, plastic, and others, and by application into biliary disease, colorectal cancer, inflammatory bowel disease, esophageal cancer, gastric/duodenal cancer, and others. End users include hospitals and ASCs, clinics, and other healthcare facilities.
Market Dynamics
Driver - Increasing ERCP Procedures: The growing number of endoscopic retrograde cholangiopancreatography procedures is driving demand for gastrointestinal stents, particularly biliary stents. More than 650,000 ERCP procedures are performed annually in the U.S., supporting the use of minimally invasive stenting procedures.
Restraint - High Cost and Limited Reimbursement: The high cost of gastrointestinal stenting procedures and self-expanding metal stents can restrict adoption. Limited reimbursement in certain countries further prevents healthcare facilities from widely utilizing advanced stenting technologies.
Opportunity - Growth of Ambulatory Surgical Centers: Increasing numbers of ASCs in the U.S., Japan, and Australia are creating opportunities for gastrointestinal stent manufacturers. The migration of therapeutic endoscopy into ASCs is supporting faster procedures and creating new procurement opportunities.
Trend - Clinical Guidelines Supporting Stenting: Increasing endorsement of specific stenting practices for colonic, esophageal, and malignant biliary conditions is improving standardization and encouraging wider adoption of gastrointestinal stents.
Challenge - Shortage of Trained Professionals: Limited availability of trained endoscopists and ERCP specialists in emerging and low-income markets creates a procedure gap. Shortages of gastroenterologists can delay diagnosis and treatment, restricting market expansion.
By Product Type: Biliary stents held the largest market share in 2025 due to increasing biliary stenting procedures for bile duct cancer and related conditions. Colonic stents are projected to grow at a CAGR of 5.6%.
By Material: Metal stents dominated the market in 2025 because their larger diameter provides longer patency and reduces blockage risk. The segment is expected to hold a 61.1% share in 2026. Plastic stents are projected to grow at a CAGR of 5.1%.
By Application: Biliary disease accounted for the largest share in 2025 and is expected to hold a 41.5% share in 2026, supported by the prevalence of biliary strictures and gallstone-related conditions. Esophageal cancer is projected to grow at a CAGR of 5.8%.
By End User: Hospitals and ASCs dominated in 2025 and are expected to hold a 73.2% share in 2026, owing to their greater expertise, resources, and procedure volumes. Clinics are projected to grow at a CAGR of 5.4%.
North America: North America remained the leading regional market, reaching USD 257.9 million in 2025. The U.S. market is estimated to reach USD 256.0 million in 2026, supported by reimbursement and growing gastrointestinal stenting procedures.
Europe: Europe is projected to reach USD 189.2 million in 2026, recording a 5.4% growth rate. The U.K., Germany, and France are expected to reach USD 26.1 million, USD 49.7 million, and USD 24.8 million, respectively.
Asia Pacific: The region is expected to reach USD 133.8 million in 2026, with India and China estimated at USD 42.6 million and USD 14.2 million, respectively.
Latin America and Middle East & Africa: Latin America is expected to reach USD 34.8 million in 2026, while the GCC market is projected to reach USD 10.5 million, supported by growing awareness and adoption of gastrointestinal procedures.
Competitive Landscape
The market is led by Boston Scientific Corporation, Olympus Corporation, and Medtronic, supported by diversified gastrointestinal stent portfolios. Other prominent players include Merit Medical Systems, CONMED Corporation, Cook, Cardinal Health, ELLA - CS, W. L. Gore & Associates, and HOBBS MEDICAL. Companies are focusing on product commercialization, distribution expansion, approvals, acquisitions, and portfolio development.
Report Coverage
The report provides comprehensive analysis of market size and forecast for 2025, 2026, and 2034, including market dynamics, trends, opportunities, challenges, segmentation, regional analysis, procedure volumes, product approvals, technological developments, competitive landscape, company profiles, and key industry developments.
Conclusion
The global gastrointestinal stent market is projected to grow from USD 615.8 million in 2025 to USD 647.8 million in 2026 and reach USD 980.6 million by 2034. Rising ERCP procedures, increasing gastrointestinal disease burden, expansion of ASCs, and wider acceptance of minimally invasive stenting will support market growth. However, high treatment costs, reimbursement limitations, and shortages of trained professionals remain key challenges. Continued product innovation, regulatory approvals, and expansion of gastrointestinal treatment capabilities are expected to shape the market's future development.
Segmentation By Product Type, Material, Application, End-user, and Region
By Product Type
By Material
By Application
By End-user
By Geography